These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3877253

  • 21. Alzheimer's disease: focal cortical changes shown by positron emission tomography.
    Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G.
    Neurology; 1983 Aug; 33(8):961-5. PubMed ID: 6603596
    [Abstract] [Full Text] [Related]

  • 22. Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
    Tune L, Brandt J, Frost JJ, Harris G, Mayberg H, Steele C, Burns A, Sapp J, Folstein MF, Wagner HN.
    Acta Psychiatr Scand Suppl; 1991 Aug; 366():61-5. PubMed ID: 1897377
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 25. Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
    McGeer PL, Kamo H, Harrop R, Li DK, Tuokko H, McGeer EG, Adam MJ, Ammann W, Beattie BL, Calne DB.
    CMAJ; 1986 Mar 15; 134(6):597-607. PubMed ID: 3512063
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
    Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE.
    Ann Neurol; 1997 Jul 15; 42(1):85-94. PubMed ID: 9225689
    [Abstract] [Full Text] [Related]

  • 29. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.
    Matochik JA, Molchan SE, Zametkin AJ, Warden DL, Sunderland T, Cohen RM.
    Acta Neurol Scand; 1995 Feb 15; 91(2):153-7. PubMed ID: 7785428
    [Abstract] [Full Text] [Related]

  • 30. Regional cerebral glucose transport and utilization in Alzheimer's disease.
    Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF.
    Neurology; 1989 Nov 15; 39(11):1427-34. PubMed ID: 2812318
    [Abstract] [Full Text] [Related]

  • 31. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
    Koss E, Friedland RP, Ober BA, Jagust WJ.
    Am J Psychiatry; 1985 May 15; 142(5):638-40. PubMed ID: 3872604
    [Abstract] [Full Text] [Related]

  • 32. NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
    Cutler NR, Heston LL, Davies P, Haxby JV, Schapiro MB.
    Ann Intern Med; 1985 Oct 15; 103(4):566-78. PubMed ID: 2864010
    [Abstract] [Full Text] [Related]

  • 33. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
    Foster NL, VanDerSpek AF, Aldrich MS, Berent S, Hichwa RH, Sackellares JC, Gilman S, Agranoff BW.
    J Cereb Blood Flow Metab; 1987 Aug 15; 7(4):415-20. PubMed ID: 3497161
    [Abstract] [Full Text] [Related]

  • 34. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H, Madison C, Baker S, Rabinovici G, Jagust W.
    Brain; 2016 Aug 15; 139(Pt 8):2275-89. PubMed ID: 27190008
    [Abstract] [Full Text] [Related]

  • 35. The functional neuroanatomy of verbal memory in Alzheimer's disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory.
    Staffaroni AM, Melrose RJ, Leskin LP, Riskin-Jones H, Harwood D, Mandelkern M, Sultzer DL.
    J Clin Exp Neuropsychol; 2017 Sep 15; 39(7):682-693. PubMed ID: 27876444
    [Abstract] [Full Text] [Related]

  • 36. NIH Conference. Brain imaging: aging and dementia.
    Cutler NR, Duara R, Creasey H, Grady CL, Haxby JV, Schapiro MB, Rapoport SI.
    Ann Intern Med; 1984 Sep 15; 101(3):355-69. PubMed ID: 6235763
    [Abstract] [Full Text] [Related]

  • 37. Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.
    Kumar A, Schapiro MB, Haxby JV, Grady CL, Friedland RP.
    J Psychiatr Res; 1990 Sep 15; 24(2):97-109. PubMed ID: 2213642
    [Abstract] [Full Text] [Related]

  • 38. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
    Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE.
    J Nucl Med; 1996 Feb 15; 37(2):201-8. PubMed ID: 8667045
    [Abstract] [Full Text] [Related]

  • 39. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
    Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L.
    JAMA; 1996 Feb 15; 273(12):942-7. PubMed ID: 7884953
    [Abstract] [Full Text] [Related]

  • 40. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
    Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.
    J Nucl Med; 1997 May 15; 38(5):797-802. PubMed ID: 9170449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.